Study tests how sleep apnea and inflammation relate to risk
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study looks at people with mild to moderate obstructive sleep apnea (OSA) to understand how inflammation and breathing disruption may affect future heart and metabolism risk. It may help explain why some people develop higher risk even with milder sleep apnea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have mild to moderate OSA, with AHI between 5 and under 30
- Have a body mass index (BMI) of 45 or less
- You are not currently taking steroids or anti-inflammatory medicines
- You do not have insulin-dependent diabetes, an autoimmune disease, or work the night shift
- You are not using CPAP right now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a sleep apnea treatment approach and looks at how it may affect your body’s metabolism. You may be eligible if you’re an adult with sleep apnea and meet health and medication rules, and possibly if you already use a PAP machine regularly.
This study looks at inflammation in the mouth tissues of children with obstructive sleep apnea (OSA). It aims to understand how the body responds to breathing interruptions during sleep.
This study compares blood samples from people with moderate-to-severe sleep apnea and those without sleep apnea to find markers that could help diagnose or treat the condition. Half of those with sleep apnea will start CPAP therapy right away, while others wait before starting.
This study looks at whether regular physical activity can make obstructive sleep apnea (OSA) less severe. It focuses on people who are not yet receiving OSA treatment and checks changes in severity over time.
This trial looks at how obstructive sleep apnea (OSA, a breathing problem during sleep) relates to heart outcomes in people with atrial fibrillation (AF). It may help doctors better predict risk and choose safer care for people who are high cardiovascular risk.
This early-stage study tests a treatment that briefly reduces oxygen during sleep to improve “plasticity,” with the goal of helping people with obstructive or mixed sleep apnea. It also looks at related conditions like high blood pressure and pre-diabetes or cholesterol problems, especially in people who haven’t tried CPAP yet.
Hear when a new Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.